Lorente L, Jiménez A, García C, Galván R, Castedo J, Martín M M, Mora M L
Intensive Care Unit, Hospital Universitario de Canarias, Ofra s/n. La Cuesta, La Laguna, Santa Cruz de Tenerife, Spain.
Eur J Clin Microbiol Infect Dis. 2008 Sep;27(9):867-71. doi: 10.1007/s10096-008-0507-5. Epub 2008 Apr 2.
The objective of this prospective observational study was to determine the influence of femoral and central internal jugular venous catheters on the incidence of catheter-related bacteremia (CRB). We included patients admitted to a 12-bed polyvalent medico-surgical intensive care unit over 4 years who received one or more femoral or central internal jugular venous catheters. We diagnosed 16 cases of CRB in 208 femoral catheters and 22 in 515 central internal jugular venous catheters. We found a higher incidence of CRB with femoral (9.52 per 1,000 catheter days) than with central internal jugular venous access (4.83 per 1,000 catheter days; risk ratio = 1.93; 95% confidence interval: 1.03-3.73; P = 0.04). Central internal jugular venous access could be considered a safer route of venous access than femoral access in minimizing the risk of central venous catheter-related bacteremia.
这项前瞻性观察性研究的目的是确定股静脉和颈内静脉中心静脉导管对导管相关菌血症(CRB)发生率的影响。我们纳入了在4年期间入住一家拥有12张床位的多科医疗外科重症监护病房、接受了一根或多根股静脉或颈内静脉中心静脉导管的患者。我们在208根股静脉导管中诊断出16例CRB,在515根颈内静脉中心静脉导管中诊断出22例。我们发现股静脉导管CRB的发生率(每1000导管日9.52例)高于颈内静脉中心静脉通路(每1000导管日4.83例;风险比=1.93;95%置信区间:1.03-3.73;P=0.04)。在将中心静脉导管相关菌血症的风险降至最低方面,颈内静脉中心静脉通路可被认为是比股静脉通路更安全的静脉通路。